ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

被引：2

作者：

Solomon, B. J. ^{[1
]}

Wu, Y-L. ^{[2
]}

Dziadziuszko, R. ^{[3
,4
]}

Barlesi, F. ^{[5
,6
]}

Nishio, M. ^{[7
]}

Ahn, J. S. ^{[8
]}

Horinouchi, H. ^{[9
]}

Hochmair, M. J. ^{[10
]}

de Marinis, F. ^{[11
]}

Migliorino, M. R. ^{[12
]}

Kurochkin, A. ^{[13
]}

Harputluoglu, H. ^{[14
]}

Planchard, D. ^{[5
,6
]}

Korphaisarn, K. ^{[15
]}

Han, J-Y. ^{[16
]}

Lohmann, T. ^{[17
]}

Gavaldon, A. Cardona ^{[18
]}

Archer, V. R. ^{[19
]}

Nowicka, M. ^{[20
]}

Noe, J. ^{[21
]}

机构：

[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[2] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Acad Med Sci, Oncol Dept,Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China

[3] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[4] Med Univ Gdansk, Early Phase Clin Trials Ctr, Gdansk, Poland

[5] Univ Paris Saclay, Dept Med Oncol, Villejuif, France

[6] Gustave Roussy, Villejuif, France

[7] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan

[8] Samsung Med Ctr, Dept Hematol & Oncol, Seoul, South Korea

[9] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[10] Karl Landsteiner Inst Lung Res & Pulm Oncol, Klin Floridsdorf, Dept Resp & Crit Care Med, Vienna, Austria

[11] European Inst Oncol IRCCS, Thorac Oncol Div, Milan, Italy

[12] San Camillo Forlanini Hosp, Pneumooncol Unit, Rome, Italy

[13] RCI Sumy Reg Clin Oncol Dispensary, Oncothorac Surg Dept, Sumy Region, Kharkiv Governo, Ukraine

[14] Inonu Univ, Dept Med Oncol, Med Fac, Turgut Ozal Med Ctr, Malatya, Turkiye

[15] Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok, Thailand

[16] Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea

[17] F Hoffmann La Roche Ltd, PD Oncol, Basel, Switzerland

[18] F Hoffmann La Roche Ltd, Data & Stat Sci, Basel, Switzerland

[19] Roche Prod Ltd, PDC, Welwyn Garden City, Herts, England

[20] F Hoffmann La Roche Ltd, Computat Sci, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, Translat Med, Basel, Switzerland

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1206MO

引用

页码：S775 / S775

页数：1

共 50 条

[21] Use and Impact of Adjuvant Chemotherapy in Patients With Resected Non-Small Cell Lung Cancer
Williams, Christina D.
Gajra, Ajeet
Ganti, Apar K.
Kelley, Michael J.
CANCER, 2014, 120 (13) : 1939 - 1947
[22] Clinical implications of cardiotoxicity and pharmacokinetics of alectinib in patients (pts) with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)
Pruis, M.
Veerman, M. G. D.
Hassing, C.
Lanser, D.
Paats, M. S.
Mathijssen, R. H.
Manintveld, O.
Dingemans, A-M. C.
ANNALS OF ONCOLOGY, 2022, 33 : S63 - S63
[23] Outcomes of patients undergoing adjuvant platinum-vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
Pender, A.
Coward, J.
Gunapala, R.
Bhosle, J.
O'Brien, M.
Popat, S.
LUNG CANCER, 2013, 79 : S12 - S12
[24] Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC).
Le Chevalier, T
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 238S - 238S
[25] Clinical experience with crizotinib in patients (pts) with advanced ALK plus non-small cell lung cancer (NSCLC) and brain metastases
Crino, L.
Ahn, M. J.
Ou, S. H. I.
Solomon, B. J.
Costa, D. B.
Shreeve, S. M.
Wiltshire, R.
Selaru, P.
Zhou, C.
Riely, G. J.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S800 - S800
[26] ALK FISH positivity and crizotinib efficacy in patients (pts) with non-small cell lung cancer (NSCLC).
Soria, Jean-Charles
Ho, Steffan N.
Varella-Garcia, Marileila
Iafrate, A. John
Solomon, Benjamin J.
Shaw, Alice T.
Blackhall, Fiona Helen
Mok, Tony
Wu, Yi-Long
Pestova, Ekaterina
Siebert, Fred W.
Wilner, Keith D.
Polli, Anna
Paolini, Jolanda
Lanzalone, Silvana
Green, Stephanie J.
Camidge, D. Ross
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[27] ALINA: a phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB-IIIA anaplastic lymphoma kinase-positive (ALK +) non-small cell cancer (NSCLC)
Rittmeyer, A.
Solomon, B.
Ahn, J. S.
Barlesi, F.
Dziadziuszko, R.
Nishio, M.
Shaw, A.
Bordogna, W.
Meyenberg, C.
Wu, Y. L.
PNEUMOLOGIE, 2020, 74 : S129 - S130
[28] Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
Zhang, Liang
Ou, Wei
Liu, Qianwen
Li, Ning
Liu, Li
Wang, Siyu
THORACIC CANCER, 2014, 5 (01) : 50 - 56
[29] The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
Almquist, Daniel R.
Savvides, Panayiotis
Ernani, Vinicius
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (03)
[30] The current status of adjuvant chemotherapy for resected non-small cell lung cancer
Socinski, MA
SEMINARS IN ONCOLOGY, 1999, 26 (05) : 27 - 33

← 1 2 3 4 5 →